Effects of the WHO Labour Care Guide on cesarean section in India: a pragmatic, stepped-wedge, cluster-randomized pilot trial
; Gibbons, Luz ; Berrueta, Mabel ; Somannavar, Manjunath ; Ciganda, Alvaro ; Rodriguez, Rocio ; Bendigeri, Savitri ; Kumar, Jayashree Ashok ; Patil, Shruti Bhavi ; Karinagannanavar, Aravind ; Anteen, Raveendra R. ; Mallappa Ramachandrappa, Pavithra ; Shetty, Shukla ; Bommanal, Latha ; Haralahalli Mallesh, Megha ; Gaddi, Suman S. ; Chikkagowdra, Shaila ; Raghavendra, Bellara ; Homer, Caroline S. E. ; Lavender, Tina ; Kushtagi, Pralhad ; Hofmeyr, G. Justus ; Derman, Richard ; Goudar, Shivaprasad Otros responsables
Fecha
01/2024
Editorial
Nature Publishing Group
Revista
Nature Medicine
Título del libro
Nombre del evento
Fecha del evento
Institución organizadora
ISSN
1078-8956
eISSN
ISBN
Idioma
Inglés
Tipo del evento
Clasificación temática
Palabras clave
Resumen
Cesarean section rates worldwide are rising, driven by medically unnecessary cesarean use. The new World Health Organization Labour Care Guide (LCG) aims to improve the quality of care for women during labor and childbirth. Using the LCG might reduce overuse of cesarean; however, its effects have not been evaluated in randomized trials. We conducted a stepped-wedge, cluster-randomized pilot trial in four hospitals in India to evaluate the implementation of an LCG strategy intervention, compared with routine care. We performed this trial to pilot the intervention and obtain preliminary effectiveness data, informing future research. Eligible clusters were four hospitals with >4,000 births annually and cesarean rates ≥30%. Eligible women were those giving birth at ≥20 weeks´ gestation. One hospital transitioned to intervention every 2 months, according to a random sequence. The primary outcome was the cesarean rate among women in Robson Group 1 (that is, those who were nulliparous and gave birth to a singleton, term pregnancy in cephalic presentation and in spontaneous labor). A total of 26,331 participants gave birth. A 5.5% crude absolute reduction in the primary outcome was observed (45.2% versus 39.7%; relative risk 0.85, 95% confidence interval 0.54-1.33). Maternal process-of-care outcomes were not significantly different, though labor augmentation with oxytocin was 18.0% lower with the LCG strategy. No differences were observed for other health outcomes or women´s birth experiences. These findings can guide future definitive effectiveness trials, particularly in settings where urgent reversal of rising cesarean section rates is needed.
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by
